Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Courses
  4. ESMO Preceptorship on Metastatic Bladder and Kidney Cancer 2022

Session 8 - Side Effects Management

Participants Clinical Case Discussion: Toxicity management of first-line Pembrolizumab combined with Axitinib in metastatic clear cell RCC

Date

12 Jul 2022

Session

Session 8 - Side Effects Management

Topics

Management of Systemic Therapy Toxicities;  Supportive Care and Symptom Management

Tumour Site

Renal Cell Cancer

Presenters

D. Spanu, IT

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

ADC side effect management

Presenter: Y. Loriot, FR

Session: Session 8 - Side Effects Management

Resources:

Slides

Webcast

IO-VEGFR TKI

Presenter: G. Von Amsberg, DE

Session: Session 8 - Side Effects Management

Resources:

Slides

Webcast

IO/IO and IO single agent

Presenter: C. Porta, IT

Session: Session 8 - Side Effects Management

Resources:

Slides

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.